▽Pharmaceutical Business Review - Industry News, Information, Research ●11/23 11:55 RespiratoryNovember 22, 2024Dyadic receives grant from Gates Foundation for RSV antibody developmentDyadic International has received a $3m grant from the Bill & Melinda Gates Foundation to develop monoclonal antibodies (mAbs) for the treatment of respiratory syncytial virus (RSV) and malaria.ContinueDrug ManufacturingMetabolic DisordersArrowhead Pharmaceuticals submits plozasiran NDA to tr